Background: We conducted a comparative survival analysis between primary androgen deprivation therapy (PADT) and radical prostatectomy (RP) based on nationwide Korean population data that included all patients with prostate cancer. Materials and methods: This study enrolled 4,538 patients with prostate cancer from the National Health Insurance Service (NHIS) database linked with Korean Central Cancer Registry data who were treated with PADT or RP between January 1, 2007, and December 31, 2014. Kaplan-Meier and multivariate survival analyses stratified by stage (localized and locally advanced) and age (<75 and ≥75 years) were performed using a Cox proportional hazards model to evaluate treatment effects. Results: Among 18,403 patients fr...
Context: Androgen deprivation therapy (ADT) for prostate cancer (PCa) represents one of the most eff...
Objectives: To test the effect of race/ethnicity on cancer-specific mortality after radical prostate...
The incidence of prostate cancer, while still lower than in Western nations, is increasing rapidly i...
[[abstract]]Introduction and objectives: The aim of the study is to analyze the treatment patterns o...
Abstract. Background:. Till date, the optimal treatment strategy for delivering adjuvant androgen de...
ObjectivesTo compare directly survival outcomes of primary androgen-deprivation therapy (PADT) in Ja...
PurposeThe optimal treatment of clinically localized prostate cancer is controversial. Most studies ...
Oral PresentationObjective: To evaluate and analyze the outcome of patients with prostate cancer tre...
Purpose: The purpose of this study was to investigate the clinical outcomes of postoperative radioth...
OBJECTIVES: To investigate the clinical and pathologic characteristics of prostate cancer in Korean ...
Context: Androgen-deprivation therapy (ADT) plays a pivotal role in the management of locally advanc...
金沢大学医薬保健研究域医学系This Practice Point commentary discusses the study by Lu-Yao et al. in which primary a...
Radical prostatectomy remains the standard treatment for early prostate cancer. Few data in the lite...
Objectives To compare directly survival outcomes of primary androgen-deprivation therapy (PADT) in J...
INTRODUCTION & OBJECTIVES: The optimal primary treatment for men with clinically high-risk prostate ...
Context: Androgen deprivation therapy (ADT) for prostate cancer (PCa) represents one of the most eff...
Objectives: To test the effect of race/ethnicity on cancer-specific mortality after radical prostate...
The incidence of prostate cancer, while still lower than in Western nations, is increasing rapidly i...
[[abstract]]Introduction and objectives: The aim of the study is to analyze the treatment patterns o...
Abstract. Background:. Till date, the optimal treatment strategy for delivering adjuvant androgen de...
ObjectivesTo compare directly survival outcomes of primary androgen-deprivation therapy (PADT) in Ja...
PurposeThe optimal treatment of clinically localized prostate cancer is controversial. Most studies ...
Oral PresentationObjective: To evaluate and analyze the outcome of patients with prostate cancer tre...
Purpose: The purpose of this study was to investigate the clinical outcomes of postoperative radioth...
OBJECTIVES: To investigate the clinical and pathologic characteristics of prostate cancer in Korean ...
Context: Androgen-deprivation therapy (ADT) plays a pivotal role in the management of locally advanc...
金沢大学医薬保健研究域医学系This Practice Point commentary discusses the study by Lu-Yao et al. in which primary a...
Radical prostatectomy remains the standard treatment for early prostate cancer. Few data in the lite...
Objectives To compare directly survival outcomes of primary androgen-deprivation therapy (PADT) in J...
INTRODUCTION & OBJECTIVES: The optimal primary treatment for men with clinically high-risk prostate ...
Context: Androgen deprivation therapy (ADT) for prostate cancer (PCa) represents one of the most eff...
Objectives: To test the effect of race/ethnicity on cancer-specific mortality after radical prostate...
The incidence of prostate cancer, while still lower than in Western nations, is increasing rapidly i...